Advancing Individualized Medicine
The Cluster for Individualized Immune Intervention (Ci3) e.V. is a non-profit organization with the aim of promoting the advancement of personalized medicine and individualized immunotherapies for the treatment of serious diseases such as cancer. By facilitating collaboration between academia, small and medium-sized enterprises, large corporations, regulators and the public, we are contributing to the development and establishment of innovative solutions in the healthcare sector.
Dr. Falk Pharma und Zedira kündigen den Start der Phase 2b „real-life“ Studie mit ZED1227 zur Behandlung der Zöliakie an08/11/2021
Digitaler Patiententag 202118/10/2021
DIGI-B-CUBE: Invitation to general coaching workshops22/09/2021
Paul Ehrlich- und Ludwig Darmstaedter-Preis geht an Özlem Türeci, Uğur Şahin und Katalin Karikó22/09/2021